Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

Hematopoietic stem cell gene therapy delivers cell-penetrating frataxin to treat Friedreich's ataxia in preclinical models

This article describes a novel gene and cell therapy approach for Friedreich's ataxia (FRDA), a neurodegenerative disease caused by frataxin

MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group

6PPD-Quinone aus Autoreifen: KI-Studie verknüpft Umweltgift mit Alzheimer-Risiko

Anti-aging drug combo dasatinib+quercetin causes brain damage in mice, study finds

A study from the University of Connecticut published in PNAS found that the dasatinib+quercetin (D+Q) drug combination, widely studied for a

Transient functional improvements in advanced Alzheimer's disease following high-dose psilocybin: a case report

This case report describes an 80-year-old Japanese-American woman with advanced Alzheimer's disease (10-year history, 5 years of severe hypo

Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study

This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu